Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Fresenius Kabi Oncology

BSE: 532545|NSE: FKONCO|ISIN: INE575G01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Fresenius Kabi Oncology is not traded in the last 30 days
Fresenius Kabi Oncology is not traded in the last 30 days
Announcements on Fresenius Kabi

31st-Dec-2013 13:35Source: BSE

Fresenius Kabi- Exit Offer (Delisting)

DSP Merrill Lynch Ltd ("Manager to the Delisting Offer") on behalf of Fresenius Kabi (Singapore) Pte Ltd (“Acquirer”) has informed this Exit Offer Public Announcement ("Exit Offer PA") to the Equi...

30th-Dec-2013 13:27Source: NSE

Fresenius Kabi Oncology Limited

DSP Merrill Lynch Limited has submitted to the Exchange a copy of Exit offer Public Announcement made by Fresenius Kabi (Singapore) Pte Ltd to the public shareholders of Fresenius Kabi Oncology Limite...

21st-Dec-2013 08:22Source: NSE

Fresenius Kabi Oncology Limited

Fresenius Kabi Oncology Limited has, with reference to the Delisting of the equity shares of the Company from the Exchange, submitted to the Exchange the details of the name, address and contact numbe...

21st-Dec-2013 08:19Source: NSE

Fresenius Kabi Oncology Limited

Members of the Exchange are hereby informed that the trading in the equity shares of Fresenius Kabi Oncology Limited shall be suspended w.e.f. January 03, 2014 (i.e. w.e.f. closing hours of trading on...

12th-Dec-2013 08:50Source: NSE

Fresenius Kabi Oncology Limited

Fresenius Kabi Oncology Limited has informed the Exchange that Dr. Patricia Grigoleit , Non-Executive Director of the Company, has resigned from the directorship of the Company with effect from Decemb...

11th-Dec-2013 21:38Source: BSE

Fresenius Kabi- Resignation of Director

Fresenius Kabi Oncology Ltd has informed BSE that Dr. Patricia Grigoleit, Non - Executive Director of the Company, has resigned from the directorship of the Company with effect from December 11, 2013.

1st-Nov-2013 12:39Source: BSE

Fresenius Kabi- Post Delisting Offer

DSP Merrill Lynch Ltd ("Manager to the Delisting Offer") on behalf of Fresenius Kabi (Singapore) Pte Ltd (“Acquirer”) has informed this Post Offer Public Announcement ("Post Offer PA") to the Publ...

31st-Oct-2013 13:09Source: NSE

Fresenius Kabi Oncology Limited

DSP Merrill Lynch Limited has submitted to the Exchange a copy Post offer Public Announcement ("Post Offer PA") is being issued by Fresenius Kabi (Singapore) Pte Ltd ("Acquirer") to the Public Shareho...

24th-Oct-2013 15:32Source: NSE

Fresenius Kabi Oncology Limited

Fresenius Kabi Oncology Limited has submitted to the exchange the standalone financial results for the period ended 30-sep-2013.

24th-Oct-2013 15:11Source: BSE

Fresenius Kabi- Financial Results & Limited Review for Sept 30, 2013

Fresenius Kabi Oncology Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2013.

1 2 3 4 5 Next >>
Quick Links for Fresenius Kabi Oncology
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.